Vistagen Announces Results of Successful U.S. Phase 1 Study

The U.S. Phase 1 data build on successful Phase 1 and Phase 2A clinical studies of itruvone previously conducted outside the U.S.


Itruvone was well-tolerated and demonstrated a favorable safety and... | June 21, 2023

Related Keywords

Mexico , United Kingdom , United States , British , American , Shawn Singh , , Chief Executive Officer , Published Phase , Major Depressive , Hamilton Depression Scale , Placebo Controlled Trial , British Journal , Fast Track ,